The AJMC® COPD compendium is a comprehensive resource for clinical news and expert insights for chronic obstructive pulmonary disease.
The Benefits and Challenges of Targeted Treatments in Severe and Uncontrolled Asthma: Opportunities in Managed Care
1.0 Credit / Pulmonology/Respiratory
View More
Uncovering the Economic Burden of Chronic Cough and the Promising Role of Emerging Targeted Therapies
3.0 Credits / Pulmonology/Respiratory
View More
An Article in the American Journal of Managed Care’s Evidence-Based Oncology: Navigating the Complexities of Frontline Immunotherapy in NSCLC
2 Credits / Oncology, Pulmonology/Respiratory
View More
Perspectives on Emerging Data for the Use of Immunotherapy in the Treatment of Early-Stage Non-Small Cell Lung Cancer
1.5 Credits / Oncology, Pulmonology/Respiratory
View More
Evolving Treatment Strategies in the Management of Pulmonary Arterial Hypertension: Key Insights for the Pharmacist, featuring a Patient Perspective
1.5 Credits / Pulmonology/Respiratory
View More
Advances in EGFR Exon 20 Insertion-Positive Non–Small Cell Lung Cancer: A Focus on Specialty Pharmacy Interventions
1.5 Credits / Oncology, Pulmonology/Respiratory
View More
Advances and Best Practices for Managed Care Pharmacists and the Treatment of Patients with Alpha-1 Antitrypsin Deficiency
1.0 Credit / Pulmonology/Respiratory
View More
COPD Linked to 28-Day All-Cause Mortality in Patients With Sepsis
November 14th 2023Compared with those without chronic obstructive pulmonary disease (COPD), patients with both sepsis and COPD had higher intensive care unit (ICU) mortality rates, longer ICU stays, and higher in-hospital mortality rates.
Read More
Accelerated Aging Associated With COPD, Impaired Lung Function
November 7th 2023High levels of phenotypic age acceleration (PhenoAgeAccel) were found to have a more significant effect on lung function in patients with chronic obstructive pulmonary disease (COPD), older patients, and White patients.
Read More
Study: Heated Tobacco Products May Be Safer Than Combustible Cigarettes in COPD
October 20th 2023Researchers found that heated tobacco products can reduce risks of exacerbations and exposure to toxic chemicals compared with combustible cigarettes in patients with chronic obstructive pulmonary disease (COPD).
Read More
Promising Results for Dupilumab in Treatment of Moderate to Severe COPD With Type 2 Inflammation
September 28th 2023New data on dupilumab demonstrate the drug’s potential usefulness in treating type 2 inflammation, a role central to respiratory diseases, including chronic obstructive pulmonary disease (COPD).
Read More
Patients With COPD Developed Depression During Early Pandemic Stages, Study Says
September 25th 2023Researchers found that approximately 17% of respondents with chronic obstructive pulmonary disease (COPD) and no lifetime history of depression developed depression during the early stages of the COVID-19 pandemic, while approximately 52% who had COPD and a history of depression experienced a recurrence of depressive symptoms.
Read More
Study Highlights Association of COPD and CVDs, Need for Prevention and Management
September 22nd 2023Among adults 40 years and older with chronic obstructive pulmonary disease (COPD), there is a higher prevalence of cardiovascular diseases (CVDs) compared with a general population without COPD.
Read More
Depression Can Impact Smoking Cessation in Patients With COPD, Study Says
September 13th 2023Researchers noted that the relationships between smoking, chronic obstructive pulmonary disease (COPD), and depression must be recognized to effectively manage the complicated care needs for this patient population.
Read More
Local-Level Chronic Disease, Social Vulnerability Measures Help Inform COPD Planning Efforts
September 9th 2023The researchers demonstrated how to jointly examine prevalence estimates of chronic obstructive pulmonary disease (COPD) from PLACES and social vulnerability measures from the Social Vulnerability Index developed by the CDC and the Agency for Toxic Substances and Disease Registry.
Read More
Theory-Based Smoking Cessation Interventions Positively Affect Patients With COPD Who Smoke
August 14th 2023Theory-based smoking cessation interventions helped to motivate patients with chronic obstructive pulmonary disease (COPD) who smoke to quit, ultimately improving their quality of life and lung function.
Read More
COPD Exacerbations More Common in Unmedicated Patients, but Many Remain Untreated
August 4th 2023Most chronic obstructive pulmonary disease (COPD) exacerbations were observed in those not treated with controller medications, but less than half of patients in the study received controller medications, even after exacerbations.
Read More
Sedentary Behavior in Patients With COPD Detected Using Novel Questionnaire
July 1st 2023This new questionnaire could help physicians more easily detect sedentary behaviors among patients with chronic obstructive pulmonary disease (COPD), which standard questionnaires have had difficulty identifying.
Read More
Health Care Professionals’ Implicit Bias May Affect Treatment Referrals for Smokers With COPD
June 30th 2023Researchers found that health care professionals who refer patients with chronic obstructive pulmonary disease (COPD) to pulmonary rehabilitation have a negative bias toward smoking and a positive bias toward exercising, which could affect how they present rehabilitation options.
Read More
COPD in Patients With Type 2 Diabetes Associated With Increased Overall, Respiratory Mortality
June 21st 2023Researchers found that those with both type 2 diabetes and chronic obstructive pulmonary disease (COPD) had lower all-cause and respiratory-cause mortality survival probabilities than those without COPD.
Read More
Video-Based Education Improves Inhaler Use Among Adults With COPD
June 16th 2023A video-based teach-to-goal (TTG) intervention was able to improve inhaler technique over time among patients with chronic obstructive pulmonary disease (COPD) and asthma, according to a randomized controlled trial.
Read More